|
Market Closed -
Xetra
11:35:36 2026-09-23 EDT
|
5-day change | 1st Jan Change | ||
| 12.87 EUR | -1.83% |
|
-5.30% | -26.96% |
| 09-15 | Weak Chemical Sector Backdrop: Evonik Weighed Down by Downgrade | DP |
| 09-15 | LANXESS AG : JP Morgan remains Neutral | ZD |
Company Valuation: LANXESS AG
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 4,701 | 3,255 | 2,450 | 2,036 | 1,521 | 1,111 | - | - |
| Change | - | -30.76% | -24.75% | -16.88% | -25.28% | -26.96% | - | - |
| Enterprise Value (EV) 1 | 6,946 | 7,069 | 4,948 | 4,417 | 3,544 | 3,184 | 3,143 | 3,124 |
| Change | - | 1.77% | -30.01% | -10.72% | -19.76% | -10.18% | -1.28% | -0.61% |
| P/E | 17.6x | 17.7x | 5.53x | -11.5x | -2.64x | -4.57x | -6.6x | -8.18x |
| PBR | 1.25x | 0.74x | 0.54x | 0.44x | 0.44x | 0.34x | 0.34x | 0.37x |
| PEG | - | -0.6x | 0x | 0x | -0x | 0.1x | 0.2x | 0.4x |
| Capitalization / Revenue | 0.62x | 0.4x | 0.36x | 0.32x | 0.27x | 0.19x | 0.19x | 0.18x |
| EV / Revenue | 0.92x | 0.87x | 0.74x | 0.69x | 0.62x | 0.55x | 0.53x | 0.52x |
| EV / EBITDA | 6.88x | 7.6x | 9.66x | 7.19x | 6.95x | 6.46x | 5.78x | 5.34x |
| EV / EBIT | 13.9x | 18.2x | -93.4x | 83.3x | -131x | 149x | 39.1x | 31.3x |
| EV / FCF | -174x | -28.5x | 9.66x | 23.5x | -118x | 57.9x | 33.1x | 21.5x |
| FCF Yield | -0.58% | -3.51% | 10.3% | 4.26% | -0.85% | 1.73% | 3.02% | 4.65% |
| Dividend per Share 2 | 1.05 | 1.05 | 0.1 | 0.1 | 0.1 | 0.1 | 0.211 | 0.2875 |
| Rate of return | 1.93% | 2.79% | 0.35% | 0.42% | 0.57% | 0.78% | 1.64% | 2.23% |
| EPS 2 | 3.09 | 2.13 | 5.13 | -2.05 | -6.68 | -2.816 | -1.95 | -1.573 |
| Distribution rate | 34% | 49.3% | 1.95% | -4.88% | -1.5% | -3.55% | -10.8% | -18.3% |
| Net sales 1 | 7,557 | 8,088 | 6,714 | 6,366 | 5,673 | 5,767 | 5,903 | 6,055 |
| EBITDA 1 | 1,010 | 930 | 512 | 614 | 510 | 493 | 544 | 584.8 |
| EBIT 1 | 500 | 389 | -53 | 53 | -27 | 21.33 | 80.41 | 99.68 |
| Net income 1 | 267 | 250 | 443 | -177 | -577 | -250.3 | -114.9 | -69.51 |
| Net Debt 1 | 2,245 | 3,814 | 2,498 | 2,381 | 2,023 | 2,072 | 2,032 | 2,012 |
| Reference price 2 | 54.50 | 37.70 | 28.37 | 23.58 | 17.62 | 12.87 | 12.87 | 12.87 |
| Nbr of stocks (in thousands) | 86,258 | 86,346 | 86,346 | 86,346 | 86,346 | 86,346 | - | - |
| Announcement Date | 3/11/22 | 3/15/23 | 3/14/24 | 3/19/25 | 3/18/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.66x | 0.56x | 6.5x | 0.76% | 1.3B | |
| 19.33x | 3.42x | 9.7x | 2.05% | 69.05B | |
| 12.24x | 0.93x | 7.75x | 4.4% | 51.02B | |
| 56.04x | 8.98x | 38.26x | 0.97% | 16.74B | |
| 12.9x | 0.86x | 6.01x | 2.82% | 13.69B | |
| 11.88x | 0.74x | 4.79x | 2.83% | 10.26B | |
| 15.69x | 0.71x | 7.71x | 3.14% | 9.95B | |
| 36.9x | 1.68x | 8.9x | 2.05% | 9.22B | |
| 4.48x | 0.64x | 2.68x | 4.91% | 8.62B | |
| 31.49x | 4.31x | 18.44x | 0.37% | 7.86B | |
| Average | 19.63x | 2.28x | 11.07x | 2.43% | 19.77B | |
| Weighted average by Cap. | 20.09x | 2.61x | 10.99x | 2.76% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- LXS Stock
- Valuation LANXESS AG
Select your edition
All financial news and data tailored to specific country editions
